Morning Overview on MSN
A cell therapy for an aggressive childhood leukemia just won breakthrough status
Children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia now have a new reason to pay attention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results